Tag
Tag: Inflammatory Disease
€18M to Fund First-in-Class Systemic Sclerosis Drug
Boost For Inflammatory Disease Biotech NodThera With €49M Series B
Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III
Update: Abivax’s Ulcerative Colitis Drug Effective Long-Term
French Biotech to Develop Septic Shock Therapy with €39M Series B
Swedish Ulcerative Colitis Treatment Makes Phase II Comeback
This Biotech Uses Messenger RNA to Treat Lethal Lung Inflammation
Atlantic Healthcare’s Inflammatory Bowel Disease RNA Drug Fails Phase III
British Biotech Raises €11M to Market Personalized Medicine Test
German Biotech Breath Therapeutics Acquired in Deal Worth up to €500M